ctDNA in non-cutaneous melanoma—In uveal melanoma (UM), recurrent mutations affecting GNA11, GNAQ, PLCβ4 or CYSLTR2 are found in the majority of patients and, even if they are not determinants of prognosis, they can represent targetable mutations in the blood [37,109]. This evidence concerns the gene GNAQ and uveal melanoma.